RZ, Q-CH, and PS wrote the first draft of the manuscript and interpreted the data analysis
Adjusting dose based on response Initial dosing represents a starting point, not a final destination
The results were striking: Weight Loss: At 24 weeks, retatrutide achieved mean weight reductions of 7.2% (1 mg), 12.9% (4 mg), 17.3% (8 mg), and 17.5% (12 mg), compared to 1.6% for placebo
A bacteriostatic water vial from a reliable supplier will clearly state the benzyl alcohol concentration and sterility specifications on the label
They work on the same pharmaceutical mechanism as GLP-1 inhibitors, so a DPP-4 could be a suitable alternative until semaglutide is available, he said